DPP4 and heart failure: The cardiovascular (CV) safety data on the effects of DPP-4 are conflicting since some randomized clinical trials and some real-life studies have reported an increased risk of hospitalizations for heart failure [19], while a recent meta-analysis shows that DPP-4 inhibitors do not increase the risk of heart failure [20].